Perspectives on Enquiry & Evidence

Ever since the first immune checkpoint inhibitor was approved for market nearly twelve years ago, the industry has..

Scientists at Cytel recently published a paper in the Journal of the American Medical Association (JAMA). Among the..

  Immunotherapy has brought us many promises, most notably, of a future where humans are able to harness their body’s..